FDA recall D-0854-2018

Product

HYDROmorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride, 1 mL Total Volume in 3 mL syringe, Rx, PharMEDium Services, LLC, Dayton, NJ

Reason for recall

Superpotent and Subpotent

Distribution

Nationwide

Key facts

Status

Terminated

Initiation date

2018-06-05

Report date

2018-06-20

Termination date

2019-02-06

Voluntary/Mandated

Voluntary: Firm initiated

Location

Dayton, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0854-2018